The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes

Blood

Volumn 116, Issue 13, 2010, Pages 2304-2314

  Li, Xiang ^a   Marcondes, A Mario ^a,b   Gooley, Theodore A ^a   Deeg, H Joachim ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HELIX LOOP HELIX PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PHOSPHOLIPASE C GAMMA1; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA;

EID: 77957714063     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-242313     Document Type: Article

References (55)

1. Greenberg PL. Myelodysplastic syndrome. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 2000:1106-1129.
2. Kerbauy DMB, Deeg HJ. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Hematol. 2007;35(11):1739-1746.
3. Mundle SD, Venugopal P, Cartlidge JD, et al. Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 1996;88(7):2640-2647. (Pubitemid 26327516)
4. Raza A, Mundle S, Shetty V, et al. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol. 1996;63(4):265-278.
5. Gersuk GM, Beckham C, Loken MR, et al. A role for tumor necrosis factor-α, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol. 1998;103(1):176-188.
6. Deeg HJ, Gotlib J, Beckham C, Dugan K, Appelbaum F, Greenberg P. Soluble TNF receptor fusion protein (TNFR:Fc;Enbrel) in the treatment of patients with myelodysplastic syndrome (MDS) [abstract]. Blood. 2000;96(11):Abstract 625.
7. Stirewalt DL, Mhyre AJ, Marcondes M, et al. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS? Br J Haematol. 2008;140:444-453.
8. Li X, Bryant E, Deeg HJ. Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int J Hematol. 2004;80(2):140-145. (Pubitemid 39201567)
9. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86(1):268-276.
10. Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science. 2008;322(5909):1861-1865.
11. Marcondes AM, Mhyre AJ, Stirewalt DL, Kim S-H, Dinarello CA, Deeg HJ. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci U S A. 2008;105(8):2865-2870.
12. Mhyre A, Marcondes AM, Spaulding EY, Deeg HJ. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD. Blood. 2009;113(3):649-658.
13. Marcondes AM, Bair S, Rabinovitch PS, Gooley T, Deeg HJ, Risques RA. No telomere shortening in marrow stroma from patients with MDS. Ann Hematol. 2009;88(7):623-628.
14. Seal S, Hockenbery DM, Spaulding EY, Kiem H-P, Abbassi N, Deeg HJ. Differential responses of FLIP(long) and FLIP(short)-overexpressing human myeloid leukemia cells to TNF-a and TRAIL-initiated apoptotic signals. Exp Hematol. 2008;36(12):1660-1672.
15. Zhang X, Wang Q, Ling MT, Wong YC, Leung SC, Wang X. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. Int J Cancer. 2007;120(9):1891-1898.
16. Šošic D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kB activity. Cell. 2003;112(2):169-180.
17. Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005;65(12):5153-5162.
18. Shiota M, Izumi H, Onitsuka T, et al. Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene. 2008;27(42):5543-5553.
19. Stasinopoulos IA, Mironchik Y, Raman A, Wildes F, Winnard P Jr, Raman V. HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J Biol Chem. 2005;280(3):2294-2299.
20. Christiansen DH, Andersen MK, Pedersen-Bjergaard J. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol. 2001;19(5):1405-1413.
21. Nakamura S, Ohnishi K, Yoshida H, et al. Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF. Cytokines Cell Mol Ther. 2000;6(2):61-70.
22. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood. 1995;85(4):997-1005.
23. Kerbauy DMB, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ. NF-kB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). Blood. 2005;106(12):3917-3925. (Pubitemid 41739032)
24. Graf L, Iwata M, Torok-Storb B. Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a [letter]. Blood. 2002;100(4):1509-1511.
25. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood. 1995;85(4):997-1005.
26. Ohtsuka T, Ryu H, Minamishima YA, et al. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol. 2004;6(2):121-128.
27. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927-939. (Pubitemid 38798858)
28. Diamond MS, Staunton DE, de Fougerolles AR, et al. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol. 1990;111(6 Pt 2):3129-3139.
29. Bai XC, Liu AL, Deng F, et al. Phospholipase C-gamma1 is required for survival in heat stress: involvement of protein kinase C-dependent Bcl-2 phosphorylation. J Biochem (Tokyo). 2002;131(2):207-212.
30. Hong JH, Moon SJ, Byun HM, et al. Critical role of phospholipase Cgamma1 in the generation of H2O2-evoked [Ca2+]i oscillations in cultured rat cortical astrocytes. J Biol Chem. 2006;281(19):13057-13067.
31. Marcondes AM, Li X, Gooley T, Milless B, Deeg HJ. Identification of DJ-1/Park-7 as a determinant of stroma-dependent and TNFa-induced apoptosis in MDS by using mass spectrometry and phosphopeptide analysis. Blood. 2010;115(10):1993-2002.
32. Deeg HJ, Huss R. Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment. Bone Marrow Transplant. 1993;12:425-430. (Pubitemid 23328353)
33. Greenberger JS, Fitzgerald TJ, Anklesaria P. Recent studies of the hematopoietic microenvironment in long-term bone marrow cultures. Immunol Res. 1989;8:226-235.
34. Lemischka IR. Microenvironmental regulation of hematopoietic stem cells. Stem Cells. 1997;15(suppl 1):63-68. (Pubitemid 127701301)
35. Ramakrishnan A, Awaya N, Bryant E, Torok-Storb B. The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS [letter]. Blood. 2006;108(2):772-773. (Pubitemid 44061386)
36. Wiendl H, Hohlfeld R, Kieseier BC. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 2005;26(7):373-380.
37. Kerbauy DMB, Lesnikov V, Torok-Storb B, Bryant E, Deeg HJ. Engraftment of distinct clonal MDSderived hematopoietic precursors in NOD/SCID- b2microglobulin- deficient mice after intramedullary transplantation of hematopoietic and stromal cells [letter]. Blood. 2004;104(7):2202-2203. (Pubitemid 39297881)
38. Gullaud M, Delanoue R, Silber J. A Drosophila model to study the functions of TWIST orthologs in apoptosis and proliferation. Cell Death Differ. 2003;10(6):641-651. (Pubitemid 36675726)
39. El Ghouzzi V, Legeai-Mallet L, Aresta S, et al. Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum Mol Genet. 2000;9(5):813-819.
40. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 1999;13(17):2207-2217. (Pubitemid 29426726)
41. Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002;161(5):1881-1891.
42. Yan-Qi Z, Xue-Yan G, Shuang H, et al. Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology. 2007;39(5):470-475.
43. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004;64(15):5270-5282. (Pubitemid 39006547)
44. Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion. Neoplasia. 2005;7(9):824-837.
45. Shiota M, Izumi H, Tanimoto A, et al. Programmed cell death protein 4 down-regulates Ybox binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res. 2009;69(7):3148-3156.
46. Ikediobi ON, Davies H, Bignell G, et al. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther. 2006;5(11):2606-2612. (Pubitemid 44848987)
47. Terauchi M, Kajiyama H, Yamashita M, et al. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma. Clin Exp Metastasis. 2007;24(5):329-339.
48. Shelton EL, Yutzey KE. Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev Biol. 2008;317(1):282-295.
49. Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC. Characterization of adhesion molecules on human myeloma cell lines. Blood. 1992;80(9):2306-2314.
50. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
51. Passam FH, Tsirakis G, Boula A, et al. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. Clin Lab Haematol. 2004;26(6):391-395.
52. Mitteregger R, White A, Weber C, et al. In vitro cell culture systems as the basis for an extracorporeal blood purification strategy in multiorgan failure treatment. Ther Apher. 1999;3(3):257-263.
53. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of antiapoptotic proteins. Leukemia. 2002;16(9):1713-1724.
54. Garrido SM, Appelbaum FR, Willman CL, Banker DE. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol. 2001;29:448-457.
55. Kawagoe H, Kandilci A, Kranenburg TA, Grosveld GC. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice. Cancer Res. 2007;67(22):10677-10685. (Pubitemid 350145893)